Cagri-Sema Blend 10mg
Pre-blended stack for comparative research work.
Pre-blended Cagrilintide + Semaglutide research stack — amylin analog combined with GLP-1 agonist for dual-hormone metabolic research.
Proposed mechanism
Cagrilintide activates amylin/calcitonin receptors; semaglutide activates GLP-1. Combination targets two distinct satiety pathways and is a central research design in next-generation incretin biology.
Research highlights
- Dual amylin + GLP-1 research stack
- Co-lyophilized cagrilintide + semaglutide
- Research-grade material, per-component COA
- Weekly-dosing research profile
Research protocol notes
Reconstitute under sterile technique with bacteriostatic water. Typical volumes range from 1–3 mL depending on the target working concentration. Swirl gently — do not shake — to avoid peptide shearing.
Stacking and comparative studies
Pre-stacked research design.
Handling and storage
Lyophilized powder is stable at ambient shipping temperatures. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 28 days. For long-term storage of unreconstituted vials, freeze at −20 °C and protect from light.
Frequently asked
What ratio is the blend?
5 mg cagrilintide + 10 mg semaglutide in the standard format.
Why combine the two?
Amylin and GLP-1 target different satiety pathways. Combined activation is proposed to produce additive or synergistic metabolic endpoints.
How is it reconstituted?
Single-vial reconstitution with BAC water — standard peptide handling.
Weekly or more frequent?
Both components have multi-day half-lives, supporting weekly research protocols.
